19 SI S. Christensen and L.R. Serbus Table S7 Potential Ctra-Regulated

Total Page:16

File Type:pdf, Size:1020Kb

19 SI S. Christensen and L.R. Serbus Table S7 Potential Ctra-Regulated Table S7 Potential CtrA‐regulated genes in fully sequenced Wolbachia strains wOo locus name wBm locus name Total # CtrA binding sites 125 115 # genes adjacent to a CtrA 34 40 binding site wOo_01470 DNA polymerase III delta subunit Wbm0170 Preprotein translocase subunit SecG wOo_01880 50S ribosomal protein L25 Wbm0295 Protein chain release factor B wOo_02570 preprotein translocase subunit SecA Wbm0343 Translation elongation factor EF‐Tu, GTPase wOo_05860 protein chain release factor B Wbm0393 DNA‐directed RNA polymerase sigma 70 subunit, RpoD Translation/ Protein synthesis wOo_06100 methionyl‐tRNA synthetase Wbm0464 Seryl‐tRNA synthetase wOo_00730 cysteinyl‐tRNA synthetase (@start) Wbm0528 Transcription termination factor, rho wOo_01850 tRNA‐His wOo_08210 transcription termination factor Rho wOo_02540 small protein A tmRNA‐binding wOo_06430 DNA polymerase I Wbm0171 RadC‐like DNA repair protein wOo_05460 CtrA response regulator Wbm0305 Ribonuclease HI Wbm0596 CtrA response regulator DNA replication /repair wOo_04550 bifunctional GMP synthaseglutamine amidotransferase protein Wbm0101 2‐methylthioadenine synthetase wOo_04050 aspartate carbamoyltransferase catalytic subunit (@start) Wbm0142 Predicted phosphatase wOo_07980 putative glycerol‐3‐phosphate acyltransferase Pls X (@start) Wbm0446 Dihydroorotase, PyrC wOo_04140 S‐adenosyl‐methyltransferase MraW Wbm0588 Acetyl‐CoA carboxylase, carboxyltransferase component wOo_00570 SAM‐dependent methyltransferase Wbm0017 NADH:ubiquinone oxidoreductase 17.2 kD subunit wOo_02300 NADH dehydrogenase I subunit F Wbm0517 Nitroreductase wOo_02550 ribonucleotide‐diphosphate reductase subunit beta Wbm0597 Glycerol‐3‐phosphate dehydrogenase wOo_03050 Signal peptidase I Wbm0735 Citrate synthase wOo_05030 dihydroorotate dehydrogenase 2 wOo_05450 glycerol‐3‐phosphate dehydrogenase Metabolism wOo_06790 phosphatidylglycerophosphate synthase wOo_06800 malic enzyme wOo_07780 UDP‐N‐acetylmuramyl pentapeptide synthase wOo_09340 citrate synthase wOo_05870 MgCoNi transporter MgtE Wbm0447 Ankyrin repeat‐containing protein and possible domain WF‐3 wOo_01800 putative monovalent cationH+ antiporter subunit B (@start) Wbm0294 Mg/Co/Ni transporter MgtE wOo_06290 membrane protease subunit stomatinprohibitin‐like protein Wbm0670 Uncharacterized conserved protein, YebC family ABC‐type protease secretion system ATPase and permease component wOo_08410 Wbm0016 Multisubunit Na+/H+ antiporter, MnhD subunit AprD ABC‐type transport system involved in resistance to organic solvents wOo_09650 Wbm0175 ABC‐type Mn2+/Zn2+ transport system, permease component Membrane associated auxiliary component Wbm0293 ABC‐type phosphate transport system, periplasmic component Wbm0296 Ankyrin repeat‐containing protein Wbm0394 Ankyrin repeat‐containing protein Wbm0463 Predicted membrane‐associated or secreted protein Wbm0768 Membrane protease subunit, stomatin/prohibitin homolog Wbm0060 Predicted protein Phage‐related wOo_00580 hypothetical protein Wbm0109 Predicted protein wOo_06270 hypothetical protein Wbm0141 Predicted protein wOo_07770 hypothetical protein Wbm0274 Predicted protein wOo_10100 hypothetical protein Wbm0659 Predicted protein Wbm0085 Predicted protein Wbm0089 Predicted protein Unknown Function Wbm0484 Predicted protein Wbm0659 Predicted protein Wbm0712 Predicted protein Wbm0752 Predicted protein WF‐3 Wbm0767 Predicted protein Wbm0516 Uncharacterized conserved protein Listed locus IDs identified as containing a CtrA‐binding site if either 8‐mer or 9‐mer consensus sequences found within ‐450bp upstream of the start of an annotated ORF, regardless of +/‐ strand orientation Blue entries indicate the 8‐mer consensus TTAACCAT Black entries indicate the 9‐mer consensus TTAA(N7)TTAAC (@start) = consensus site positioning corresponds with start of the ORF/locus indicated 19 SI S. Christensen and L.R. Serbus Table S7 continued wPip Pel locus name wHa locus name 109 98 49 53 WPa_0077 cysteinyl‐tRNA synthetase (@start) wHa_03030 lepA, Elongation factor 4 WPa_0671 rpmE, ribosomal protein L31 wHa_04750 prfB, Peptide chain release factor 2 WPa_0561 tuf, translation elongation factor Tu wHa_00240 serS, Seryl‐tRNA synthetase WPa_0829 truB, trna pseudouridine synthase b wHa_06730 rho, Transcription termination factor Rho WPa_0215 transposase wHa_10010 priA, Primosomal protein N', superfamily II helicase WPa_0585 two component transcriptional regulator (ctrA) wHa_07740 uvrA, Excinuclease ABC, subunit A WPa_0766 primosomal protein N wHa_00600 ruvC, Crossover junction endodeoxyribonuclease RuvC WPa_0769 recR, recombination protein RecR wHa_06210 ctrA, Two component transcriptional regulator WPa_1146 ruvC, crossover junction endodeoxyribonuclease WPa_0151 Antioxidant, AhpC/Tsa family wHa_01350 Ferredoxin, 4Fe‐4S WPa_0211 haloacid dehalogenase‐like hydrolase wHa_05350 coxB, Cytochrome c oxidase subunit 2 WPa_0721 asd, aspartate‐semialdehyde dehydrogenase wHa_06300 era, GTP‐binding protein Era (@start) WPa_0801 purC, phosphoribosylaminoimidazole‐succinocarboxamide synthase wHa_06810 Cytochrome c family protein WPa_0942 O‐methyltransferase family protein wHa_08560 purC, Phosphoribosylaminoimidazole‐succinocarboxamide synthase WPa_1060 multiple resistance and ph regulation protein f wHa_09740 pgk, Phosphoglycerate kinase WPa_0431 Putative virulence factor RhuM protein wHa_10900 sucA, 2‐oxoglutarate dehydrogenase E1 component WPa_0526 peptidyl‐prolyl cis‐trans isomerse D, putative wHa_02160 UDP‐N‐acetylglucosamine pyrophosphorylase‐related protein WPa_0570 clpP, ATP‐dependent Clp protease, proteolytic subunit ClpP wHa_02630 Putative siRNA binding protein (contains 2PAZ domains) murG, UDP‐N‐acetylglucosamine‐‐N‐acetylmuramyl‐(pentapeptide) WPa_0574 polysaccharide deacetylase, putative wHa_05250 pyrophosphoryl‐undecaprenol N‐acetylglucosamine transferas WPa_0575 Mg chelatase‐related protein wHa_05350 coxB, Cytochrome c oxidase subunit 2 WPa_0584 glycerol‐3‐phosphate dehydrogenase (NAD+) wHa_06110 Polysaccharide deacetylase, putative WPa_0634 cytochrome b561 wHa_06120 Mg chelatase‐related protein murG, UDP‐N‐acetylglucosamine‐‐N‐acetylmuramyl‐(pentapeptide) WPa_0898 wHa_06200 gpsA, Glycerol‐3‐phosphate dehydrogenase pyrophosphoryl‐undecaprenol N‐acetylglucosamine transferase WPa_0983 gltA, citrate synthase wHa_06750 Peptidyl‐prolyl cis‐trans isomerase D, putative WPa_1017 nadh dehydrogenase (quinone) wHa_08170 nuoF, NADH:ubiquinone oxidoreductase subunit F WPa_1018 NADH:ubiquinone oxidoreductase wHa_08570 purM, Phosphoribosylformylglycinamidine cyclo‐ligase wHa_09250 Putative NADH:ubiquinone oxidoreductase subunit wHa_09260 NADH‐ubiquinone oxidoreductase family protein wHa_09630 gltA, citrate synthase WPa_0296 Ankyrin repeat domain protein wHa_02680 Ankyrin repeat domain protein WPa_0801 putative membrane protein (@start) wHa_03370 Ankyrin repeat domain protein WPa_1264 major facilitator family transporter wHa_04740 Magnesium transporter MgtE WPa_1376 mgtE, magnesium transporter wHa_08650 Permease, putative WPa_0296 Ankyrin repeat domain protein wHa_04820 Cation ABC transporter, permease protein, putative WPa_0765 putative membrane protein wHa_08640 Permease, putative wHa_08650 Permease, putative WPa_0430 putative phage related protein wHa_08510 Putative phage terminase WPa_1313 Putative phage related protein wHa_09480 Putative phage terminase WPa_1355 Putative outer membrane protein (porin superfamily) WPa_0212 Hypothetical protein wHa_04520 hypothetical protein WPa_0224 Hypothetical protein wHa_08410 hypothetical protein WPa_0528 conserved hypothetical protein wHa_00230 hypothetical protein WPa_0641 Hypothetical protein wHa_00330 hypothetical protein WPa_0943 Hypothetical protein wHa_01090 hypothetical protein WPa_0275 (conserved hypothetical protein @start) wHa_02430 hypothetical protein WPa_0686 conserved hypothetical protein wHa_04610 hypothetical protein WPa_0198 hypothetical protein wHa_05260 hypothetical protein WPa_0685 hypothetical protein wHa_06070 hypothetical protein WPa_0828 hypothetical protein wHa_06080 hypothetical protein WPa_0838 hypothetical protein wHa_06130 hypothetical protein WPa_0839 hypothetical protein wHa_06740 hypothetical protein WPa_0897 hypothetical protein wHa_08580 hypothetical protein WPa_1266 hypothetical protein wHa_08630 hypothetical protein wHa_09590 hypothetical protein wHa_09770 hypothetical protein 20 SI S. Christensen and L.R. Serbus Table S7 continued wNo locus name wRi locus name 109 120 48 55 wNo_02380 rpmE, 50S ribosomal protein L31 wRi_001440 dnaQ, DNA polymerase III, epsilon subunit wNo_10050 pvfB, Peptide chain release factor 2 wRi_004150 Protein chain release factor B wNo_02650 tuf1,Elongation factor Tu 1 wRi_002950 GTP‐binding protein LepA wNo_04870 truB, tRNA pseudouridine synthase B wRi_008350 rpmE, ribosomal protein L31 wRi_009070 ribosomal slippage (transopase IS5 family) wRi_00260 seryl‐tRNA synthetase wRi_006360 rho, Transcription termination factor Rho wRi_006380 peptidyl‐prolyl cis‐trans isomerse D, putative wNo_02120 RNA‐directed DNA polymerase wRi_011780 priA, Primosomal protein N', superfamily II helicase wNo_10780 topA, DNA topoisomerase wRi_008740 uvrA, excinuclease ABC, A subunit wNo_01920 putative transposase wRi_001110 ruvC, crossover junction endodeoxyribonuclease RuvC wNo_02870 ctrA, transcriptional regulator wRi_007780 transposase wNo_03500 dnaE, DNA polymerase III, alpha subunit wRi_009640 transposase wNo_08060 ruvC, crossover junction endodeoxyribonuclease RuvC wRi_006620 radC, DNA repair protein wRi_007440 ctrA, cell cycle transcriptional regulator wNo_00590 NUDIX hydrolase wRi_001570
Recommended publications
  • Generate Metabolic Map Poster
    Authors: Pallavi Subhraveti Ron Caspi Peter Midford Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_003855395Cyc: Shewanella livingstonensis LMG 19866 Cellular Overview Connections between pathways are omitted for legibility.
    [Show full text]
  • The Clinical Biochemistry of 5'-Nucleotidase*
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 20, No. 2 Copyright © 1990, Institute for Clinical Science, Inc. The Clinical Biochemistry of 5'-Nucleotidase* F. WILLIAM SUNDERMAN JR., M.D. Departments of Laboratory Medicine and Pharmacology, University of Connecticut Medical School, Farmington, CT 06032 ABSTRACT This review delineates the subcellular distribution, biochemical charac­ teristics, and metabolic functions of 5'-nucleotidase (5'NT), summarizes the analytical biochemistry of 5'NT, and assesses the clinical significance of5'NT determinations in body fluids, cells, and tissues. Salient aspects of the clinical biochemistry of 5'NT, discussed herein, are as follows: (A) Serum 5'NT activity is generally elevated in hepatobiliary diseases, espe­ cially with intrahepatic obstruction, but, unlike serum alkaline phospha­ tase, serum 5'NT activity is not increased in infancy, childhood, preg­ nancy, or osteoblastic disorders. (B) In cancer patients, elevated serum 5'NT activity does not always indicate hepatobiliary involvement; in some cases, 5'NT may be released into serum from the primary tumor or local metastases. (C) Genetic deficiency of erythrocyte pyrimidine 5'NT activity is a common cause of hereditary non-spherocytic hemolytic anemia. (D) Acquired deficiency of erythrocyte pyrimidine 5'NT activity occurs in patients with P-thalassemia and lead poisoning. (E) 5'NT activity is low in circulating monocytes, increases markedly upon their differentiation to tissue macrophages, and subsequently diminishes during macrophage activation. (F) Lymphocyte ecto-5'NT activity, a plasma membrane marker of cell maturation, is generally low in immunodeficiency states, and undergoes characteristic changes in patients with certain lymphomas and leukemias. Introduction ribonucleosides and inorganic phos­ phate.
    [Show full text]
  • Poly (I)-Poly (C)/Oligo (Dt)-Cellulosei... Sidney Pestka, James Mcinnes
    Contents Vol. 72, No. 10 October 1975 INFORMATION TO CONTRIBUTORS ..............................iv...........................I..................... i-i AUTfHOR INDEX ................................................................................................. 4190 Physical Sciences APPLIED Adiabatic evolution of plasma equilibrium (bifurcation/isolation/weak solution/generalized differential MATHEMATICS equation/Tokamak) ............................................ H. Grad, P.N. Hu, and D. C. Stevens 3789-3793 CHEMISTRY Theoretical studies of metal-phosphate interactions: Interaction of Li+, Na+, K+, Be++, Mg++, and Ca++ with H2PO4- and (CH30)2PO2-: Implications for nucleic acid solvation (metal binding/phos- phate complexes/molecular orbital theory) ................Dennis S. Marynick and Henry F. Schaefer III 3794-3798 Maximum-valence radii of transition metals (covalent radii/enneacovalence) ............... Linus Pauling 3799-3801 Model of protein folding: Inclusion of short-, medium-, and long-range interactions (mechanism offolding/ contact free energies/range of interactions/Monte Carlo) ........... Seiji Tanaka and HaroldA. Scheraga 3802-3806 Matrix method for fhActuations and noise in kinetic systems (cross correlation function/noise power spectrum matrix/relaxation matrix/biochemical reaction kinetics/muscle contraction) .Yi-der Chen 3807-3811 MATHEMATICS Point estimates for probability moments (approximate methods/finite differences/numerical methods/prob- abilities) .......................... - ;Emilio Rosenblueth 3812-3814
    [Show full text]
  • Phosphodiesterases Expression During Murine Cardiac Development
    International Journal of Molecular Sciences Article Phosphodiesterases Expression during Murine Cardiac Development Thays Maria da Conceição Silva Carvalho 1,†, Silvia Cardarelli 1,†, Mauro Giorgi 2, Andrea Lenzi 3, Andrea M. Isidori 3 and Fabio Naro 1,* 1 Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University, 00161 Rome, Italy; [email protected] (T.M.d.C.S.C.); [email protected] (S.C.) 2 Department of Biology and Biotechnology “C. Darwin”, Sapienza University, 00185 Rome, Italy; [email protected] 3 Department of Experimental Medicine, Sapienza University, 00161 Rome, Italy; [email protected] (A.L.); [email protected] (A.M.I.) * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: 30-50 cyclic nucleotide phosphodiesterases (PDEs) are a large family of enzymes playing a fundamental role in the control of intracellular levels of cAMP and cGMP. Emerging evidence suggested an important role of phosphodiesterases in heart formation, but little is known about the expression of phosphodiesterases during cardiac development. In the present study, the pattern of expression and enzymatic activity of phosphodiesterases was investigated at different stages of heart formation. C57BL/6 mice were mated and embryos were collected from 14.5 to 18.5 days of development. Data obtained by qRT-PCR and Western blot analysis showed that seven different isoforms are expressed during heart development, and PDE1C, PDE2A, PDE4D, PDE5A and PDE8A Citation: Carvalho, T.M.d.C.S.; are modulated from E14.5 to E18.5. In heart homogenates, the total cAMP and cGMP hydrolytic Cardarelli, S.; Giorgi, M.; Lenzi, A.; activity is constant at the evaluated times, and PDE4 accounts for the majority of the cAMP hydrolyz- Isidori, A.M.; Naro, F.
    [Show full text]
  • Oxidative Stress Responses in Escherichia Coli and Salmonella Typhimurium
    MICROBIOLOGICAL REVIEWS, Dec. 1991, p. 561-585 Vol. 55, No. 4 0146-07 49/91/040561-25$02. 00/0 Copyright © 1991, American Society for Microbiology Oxidative Stress Responses in Escherichia coli and Salmonella typhimurium SPENCER B. FARR1* AND TOKIO KOGOMA2 Department of Molecular and Cellular Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115, 1 and Departments ofCell Biology and Microbiology, University of New Mexico Medical Center, Albuquerque, New Mexico 87131 2 INTRODUCTION AND SCOPE OF REVIEW ............................................................................ 561 OXIDATIVE STRESS RESPONSES .........................................................................................562 Active Oxygen Species ......................................................................................................... 562 Reactivities .....••••.•.......................•............................•.........•.......................................... 562 Sources ......................................•................•.......•.•.•..................................••...••....•.......563 Oxidative Stress and Cellular Responses .........................................................•.......•..•••••....•...563 Peroxide stress response •................•.......•.............................................................•...........564 Su peroxide stress response ...............•..........•.•........•....••....••.....................••.•••••...••.•..•..•..•.564 The two oxidative stress responses are distinct .......................................................................564
    [Show full text]
  • Bkca-Mediated PDE Regulation of Artery Tone
    BKCa-mediated PDE regulation of artery tone Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure Sarah Idres, Germain Perrin, Valérie Domergue, Florence Lefebvre, Susana Gomez, Audrey Varin, Rodolphe Fischmeister, Véronique Leblais, Boris Manoury To cite this version: Sarah Idres, Germain Perrin, Valérie Domergue, Florence Lefebvre, Susana Gomez, et al.. BKCa- mediated PDE regulation of artery tone Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure. Cardiovascular Research, Oxford University Press (OUP), 2019, 115 (1), pp.130-144. 10.1093/cvr/cvy161. hal-02463726 HAL Id: hal-02463726 https://hal.archives-ouvertes.fr/hal-02463726 Submitted on 1 Feb 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Manuscript Idres et al., BKCa-mediated PDE regulation of artery tone MS # CVR-2017-669 Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure Sarah Idres1, Germain Perrin1, Valérie Domergue2, Florence Lefebvre1, Susana Gomez1, Audrey Varin1, Rodolphe Fischmeister1, Véronique Leblais1 and Boris Manoury1. 1 Signalling and cardiovascular pathophysiology - UMR-S 1180, Univ. Paris-Sud, INSERM, Université Paris-Saclay, 92296, Châtenay-Malabry, France 2 UMS IPSIT, Univ.
    [Show full text]
  • Azido-2',3'-Dideoxynucleoside Analog Reverse Transcriptase Inhibi
    Activity Profiles & Mechanisms of Resistance of 3’-Azido-2’,3’-Dideoxynucleoside Analog Reverse Transcriptase Inhibitors of HIV-1 by Jeffrey David Meteer Bachelor of Science, St. John Fisher College, 2006 Submitted to the Graduate Faculty of the School of Medicine Molecular Virology and Microbiology Graduate Program in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Jeffrey David Meteer It was defended on July 18th, 2013 and approved by John W. Mellors, M.D. Professor and Division Chief, Dissertation Advisor Department of Medicine, Division of Infectious Diseases School of Medicine, University of Pittsburgh Daniel E. Johnson, Ph.D. Associate Professor, Committee Member Department of Pharmacology and Chemical Biology School of Medicine, University of Pittsburgh Saleem A. Khan, Ph.D. Professor, Committee Member Department of Microbiology and Molecular Genetics School of Medicine, University of Pittsburgh Paul R. Kinchington, Ph.D. Professor, Committee Member Department of Microbiology and Molecular Genetics School of Medicine, University of Pittsburgh Nicolas P. Sluis-Cremer, Ph.D. Associate Professor, Committee Member Department of Microbiology and Molecular Genetics School of Medicine, University of Pittsburgh ii Activity Profiles and Mechanisms of Resistance of 3’-Azido-2’,3’-Dideoxynucleoside Analog Reverse Transcriptase Inhibitors of HIV-1 Jeffrey David Meteer, PhD University of Pittsburgh, 2013 Copyright
    [Show full text]
  • Nucleotidase) Up-Regulation ′ CD73
    IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation This information is current as Jussi Niemelä, Tiina Henttinen, Gennady G. Yegutkin, Laura of September 29, 2021. Airas, Anna-Maija Kujari, Pertti Rajala and Sirpa Jalkanen J Immunol 2004; 172:1646-1653; ; doi: 10.4049/jimmunol.172.3.1646 http://www.jimmunol.org/content/172/3/1646 Downloaded from References This article cites 41 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/172/3/1646.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IFN-␣ Induced Adenosine Production on the Endothelium: (A Mechanism Mediated by CD73 (Ecto-5؅-Nucleotidase Up-Regulation1 Jussi Niemela¨,* Tiina Henttinen,* Gennady G. Yegutkin,* Laura Airas,* Anna-Maija Kujari,* Pertti Rajala,† and Sirpa Jalkanen2* CD73 (ecto-5؅-nucleotidase; EC 3.1.3.5) participates in lymphocyte binding to endothelial cells and converts extracellular AMP into a potent anti-inflammatory substance adenosine.
    [Show full text]
  • Disorder Index
    Disorder Index A AIP. See Acute intermittent porphyria (AIP) AARF domain-containing kinase 3 (ADCK3) defi ciency , 235 AKU. See Alkaptonuria (AKU) ABCB4 defi ciency , 557, 559, 564, 571 Alanine-glyoxylate aminotransferase (AGT) , 376, 466, 467, 471, ABCB11 defi ciency , 557, 564, 571 763, 772 ABCC2 defi ciency , 557, 564 Alanine-glyoxylate aminotransferase defi ciency (peroxisomal) , Abetalipoproteinemia (MTP) , 674, 678 467, 763 ABS. See Antley-Bixler syndrome (ABS) ALDOA defi ciency. See Aldolase A (ALDOA) defi ciency ACAD9 defi ciency. See Acyl-CoA dehydrogenase 9 (ACAD9) Aldoketoreductase 2 defi ciency, Backdoor pathway defect , 605 defi ciency Aldolase A (ALDOA) defi ciency , 269, 821 N -Acetyl-alpha- d -glucosaminidase defi ciency , 450 Aldolase B (ALDOB) defi ciency , 268, 820 N -Acetylaspartic aciduria , 143 Aldosterone synthase defi ciency , 605 Acetyl-CoA alpha-glucosaminide acetyltransferase defi ciency , 450 ALG1-CDG. See Mannosyltransferase 1 defi ciency congenital N -Acetylgalactosamine-4-sulphatase defi ciency , 450 disorders of glycosylation (ALG1-CDG) N -Acetylgalactosamine-6-sulphatase defi ciency , 450 ALG 2-CDG. See Mannosyltransferase 2 defi ciency congenital N -Acetylglucosamine-1-phosphotransferase (alpha/beta) disorders of glycosylation (ALG 2-CDG) defi ciency , 402 ALG3-CDG. See Mannosyltransferase 6 defi ciency congenital N -Acetylglucosamine-1-phosphotransferase (gamma) defi ciency , 402 disorders of glycosylation (ALG3-CDG) N -Acetylglucosamine-6-sulphatase defi ciency , 450 ALG6-CDG. See Glucosyltransferase 1 defi ciency, congenital N -Acetylglucosaminyltransferase 2 congenital defects of glycosylation disorders of glycosylation (ALG6-CDG) (MGAT2-CDG) , 484–486, 489 ALG 8-CDG. See Glucosyltransferase 2 defi ciency, congenital N -Acetylglucosaminyltransferase 2 defi ciency-CDG-IIa , 486, 496 disorders of glycosylation (ALG 8-CDG) N -Acetylglutamate synthase defi ciency , 49, 51, 715, 818 ALG9-CDG.
    [Show full text]
  • Introduction the Terms in the Subject Index for Volume 81, January
    Introduction The terms in the Subject Index for Volume 81, January-December 1984, of the PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA (Biological Sci- ences) were chosen from titles, key terms, and abstracts of articles. The index terms are alphabetized by computer; numbers, conformational prefixes, and hy- phenated Greek letters are disregarded in alphabetization. 8041 8042 Biological Sciences Subject Index Proc. Natl. Acad. Sci. USA 81 (1984) A* protein Different channel properties of Torpedo acetylcholine receptor monomers Cleavage of single-stranded DNA by the <X174 A* protein: The A*- and dimers reconstituted in planar membranes, 6222 single-stranded DNA covalent linkage, 4285 Phosphorylation of the nicotinic acetylcholine receptor by an endogenous Abelson murine leukemia virus tyrosine-specific protein kinase, 6968 Transformation-associated proteins in murine B-cell lymphomas that are Purification of the muscarinic acetylcholine receptor from porcine atria distinct from Abelson virus gene products, 4434 (Correction), 7258 Abortive infection Acetylcholine receptor-specific suppressive T-cell factor from a Virus-plasmid interactions: Mutants of bacteriophage T3 that abortively retrovirally transformed T-cell line, 7569 infect plasmid F-containing (F+) strains of Escherichia coli, 1465 Isolation and characterization of a cDNA clone for the complete protein Cytomegalovirus infects human lymphocytes and monocytes: Virus coding region of the 8 subunit of the mouse acetylcholine expression is restricted to immediate-early gene products,
    [Show full text]
  • Supplementary Information For
    1 2 3 4 5 6 Supplementary information for: 7 5-Deoxyadenosine Salvage by Promiscuous Enzyme 8 Activity leads to Bioactive Deoxy-Sugar Synthesis in 9 Synechococcus elongatus 10 Johanna Rapp, Pascal Rath, Joachim Kilian, Klaus Brilisauer, Stephanie Grond, Karl 11 Forchhammer 1 12 Results 13 14 Figure S1: Only small intracellular 5dR and 7dSh accumulation in S. elongatus. Concentration -1 -1 15 of 5dR (black dots) and 7dSh (grey squares) in S. elongatus cells [µmol*L culture*OD750 ] 16 aerated with air supplemented with 2 % CO2. 2 17 18 Figure S2: 5dR-1P accumulates in crude extracts of S. elongatus that were incubated in the 19 presence of phosphate. Accumulation of 5dR-1P shown as extracted ion chromatogram 20 [M+H, M+Na]+ (m/z 215.0315; m/z 237.0135) in crude extracts of S. elongatus, (Red – with 21 5dAdo+potassium phosphate buffer (PPB); green – with 5dAdo, no PPB; black – without 22 5dAdo, PPB). Three independent replicates are shown for each treatment. One part of the 23 samples of the crude extract assays was analysed via high resolution LC-MS (C18 Gemini, 24 solvent A: ACN+0.1 %TFA, solvent B: H2O, 1% - 20% B in 20 min, Maxis 4G ESI-QTOF). 3 25 26 Figure S3: 5dR does not accumulate in crude extracts which were incubated with 5dAdo. 27 Crude extracts from S. elongatus or S. elongatus mtnP::specR were incubated with 5dAdo in 28 the presence or absence of potassium phosphate buffer (PPB) and then analysed via thin layer 29 chromatography (TLC). TLC plate from Figure 7 (main text) was sprayed with anisaldehyde 30 after UV-visualisation.
    [Show full text]
  • Trna Biology Charges to the Front
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW tRNA biology charges to the front Eric M. Phizicky1,4 and Anita K. Hopper2,3 1Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester School of Medicine, Rochester, New York 14642, USA; 2Department of Molecular Genetics, Center for RNA Biology, Ohio State University, Columbus, Ohio 43210, USA tRNA biology has come of age, revealing an unprecedented Multiple layers of regulation of tRNA transcription level of understanding and many unexpected discoveries tRNA and rRNA genes are highly transcribed, leading to along the way. This review highlights new findings on the the production in yeast of ;3 million tRNAs per gener- diverse pathways of tRNA maturation, and on the forma- ation and 300,000 ribosomes (Waldron and Lacroute tion and function of a number of modifications. Topics of 1975), compared with about 60,000 mRNAs (Ares et al. special focus include the regulation of tRNA biosynthesis, 1999). Because of the energy devoted to tRNA and rRNA quality control tRNA turnover mechanisms, widespread transcription, and because of the required coordination of tRNA cleavage pathways activated in response to stress tRNA and ribosome function, tRNA transcription via and other growth conditions, emerging evidence of signal- RNA polymerase III (Pol III) and rRNA transcription via ing pathways involving tRNA and cleavage fragments, and Pol I need to be coordinated and regulated in response to the sophisticated intracellular tRNA trafficking that oc- cellular nutrient availability and other environmental curs during and after biosynthesis. information. The consequences of inappropriate regula- tion of tRNA transcription have been underscored by the tRNA biogenesis involves the synthesis of the initial results of Marshall et al.
    [Show full text]